Low- and No-Calorie Sweeteners Linked to Accelerated Cognitive Decline in Landmark Eight-Year Study

For decades, low- and no-calorie sweeteners have been marketed as a golden ticket for public health—a way to satisfy a sweet tooth without triggering the metabolic consequences associated with traditional table sugar. From diet sodas and flavored waters to protein bars, yogurts, and tabletop packets, these sugar substitutes are consumed by millions daily, particularly by individuals managing diabetes or attempting to curb caloric intake. However, a sweeping new study published in Neurology, the official medical journal of the American Academy of Neurology, suggests that the long-term trade-off for these chemical alternatives may exact a hidden toll on cognitive health.

The research reveals that adults who consume high amounts of low- and no-calorie sweeteners experience a significantly accelerated decline in memory and thinking skills compared to those who consume minimal amounts. While the study emphasizes an association rather than absolute causation, the findings introduce critical questions regarding the long-term neurological impacts of ultra-processed food additives. As global consumption of artificial and alternative sweeteners continues to rise alongside rates of metabolic disorders, the scientific community is being forced to take a closer look at what routine exposure to these substances means for the aging brain.

Unpacking the Study: Methodology and Scope

Led by Dr. Claudia Kimie Suemoto and her team at the University of São Paulo in Brazil, the observational study sought to bridge a significant gap in nutritional and neurological research. While the physiological impacts of sugar substitutes on weight management, gut microbiomes, and insulin resistance have been studied extensively, their relationship with central nervous system longevity has remained largely unexplored.

To investigate this connection, researchers analyzed robust data from 12,772 adult participants across Brazil. At the study’s inception, the average age of the cohort was 52 years old—a crucial developmental window for observing early markers of cognitive aging before the onset of clinical dementia or severe neurodegenerative conditions. The participants were tracked over a comprehensive eight-year period, allowing researchers to monitor subtle trajectories in mental performance over time.

At the baseline stage, participants completed exhaustive, validated dietary questionnaires detailing their food and beverage consumption over the preceding twelve months. Researchers translated these dietary habits into precise daily intake estimates for seven of the most widely used sugar substitutes on the global market: aspartame, saccharin, acesulfame-K, erythritol, xylitol, sorbitol, and tagatose.

To evaluate dosage impacts, researchers stratified the cohort into three distinct consumption groups. The lowest consumption group averaged a modest 20 milligrams per day (mg/day). The middle group consumed moderate amounts, while the highest consumption tier averaged 191 mg/day. To contextualize these figures, 191 milligrams of aspartame is roughly equivalent to the amount found in a single 12-ounce can of diet soda. Among all evaluated substances, sorbitol—a sugar alcohol frequently used in sugar-free candies and baked goods—demonstrated the highest average daily intake at 64 mg/day.

Tracking Cognitive Trajectories Over Time

To measure changes in mental faculties, researchers administered standardized cognitive assessments at three distinct intervals: the study’s beginning, midpoint, and conclusion. These evaluations were meticulously designed to test vital domains of everyday cognitive functioning, ensuring a comprehensive view of mental agility.

The testing battery focused heavily on verbal fluency, measuring a participant’s ability to rapidly retrieve and produce words under specific categories—a strong indicator of frontal lobe functioning and semantic memory. Additionally, researchers tested working memory, which dictates the brain’s capacity to temporarily hold, manipulate, and utilize complex information. Word recall and cognitive processing speed were also measured to evaluate how quickly participants could process visual and verbal stimuli and retrieve stored memories.

By comparing performance scores across the eight-year timeline, researchers established a clear baseline for normal cognitive aging within the cohort against which sweetener consumption could be measured.

Key Findings: Quantifying the Cognitive Impact

The statistical analysis revealed a striking, dose-dependent relationship between the volume of sweeteners consumed and the speed of cognitive decline.

After controlling for a wide array of confounding variables—including age, sex, baseline education levels, high blood pressure, and pre-existing cardiovascular diseases—researchers discovered that participants in the highest sweetener consumption group experienced a 62% faster decline in overall thinking and memory abilities compared to those in the lowest consumption group.

To help translate these percentages into real-world terms, the researchers calculated that this accelerated rate of decline was equivalent to approximately 1.6 additional years of cognitive aging over the course of the eight-year study. Even moderate consumption registered measurable neurological differences: participants in the middle consumption tier exhibited a 35% faster cognitive decline, translating to roughly 1.3 additional years of biological cognitive aging compared to the low-intake group.

It is vital to note that these figures represent statistical shifts in test performance rather than a direct measurement of physical brain atrophy or a guaranteed diagnosis of future dementia. Nevertheless, the scale of the association has alarmed public health advocates who view artificial and alternative sweeteners as entirely benign.

Subgroup Vulnerabilities: Adults Under 60 and Diabetics

Further granular analysis of the data revealed that the adverse associations were not distributed evenly across the entire population. Instead, certain demographic groups appeared significantly more vulnerable to the potential risks associated with high sweetener intake.

Notably, among adults younger than 60 years old, higher sweetener consumption was linked to notably faster declines in verbal fluency and overall cognitive performance. Conversely, researchers did not observe the same statistically significant association among participants older than 60. This age divergence suggests that the cumulative neurological impact of these chemical substances may manifest earlier in life, or that younger cohorts consume distinct profiles of ultra-processed products containing these additives.

Even more pronounced was the vulnerability observed among individuals with diabetes. The relationship between sweetener intake and accelerated cognitive decline was substantially stronger in participants managing diabetes than in healthy control groups. This finding introduces a complex clinical dilemma: individuals with diabetes are routinely advised by medical professionals to replace dietary sugars with low- and no-calorie alternatives to maintain glycemic control. If these very substitutes carry a secondary risk for neurological health, healthcare providers may need to reevaluate dietary counseling protocols for metabolic patients.

Examining the Individual Sweeteners

When researchers broke down the data by individual substances, six of the seven evaluated sweeteners were independently associated with faster cognitive decline, particularly in memory domains. These six substances were:

• Aspartame
• Saccharin
• Acesulfame-K
• Erythritol
• Xylitol
• Sorbitol

Tagatose emerged as the sole exception in the analysis. Researchers found no statistically significant association between tagatose consumption and cognitive decline. However, nutrition scientists caution that this lack of correlation does not prove tagatose is neuroprotective or inherently safer than its counterparts; rather, it highlights the need for dedicated, targeted research into lesser-known sweeteners.

Methodological Limitations and Scientific Caution

Despite the robust sample size and rigorous statistical controls, the study’s authors and independent experts have emphasized several important limitations that preclude definitive cause-and-effect conclusions.

First, the research relies on an observational design. While researchers adjusted for cardiovascular health, hypertension, and demographic factors, residual confounding variables—such as overall diet quality, physical activity levels, socioeconomic status, and genetic predispositions—could theoretically influence the results. It is entirely plausible that individuals who consume high quantities of diet products also engage in other lifestyle behaviors that independently affect long-term brain health.

Second, dietary information relied on self-reported questionnaires evaluating the previous year of consumption. Human recall is notoriously imperfect; participants frequently underestimate portion sizes, forget minor ingredients, or misreport dietary habits over long recall windows.

Finally, the study did not encompass every chemical sweetener or emerging sugar alcohol on the global market, meaning the findings cannot be universally generalized to every alternative sweetener available today.

Broader Implications for Public Health and the Food Industry

The publication of these findings arrives at a critical juncture for the global food and beverage industry. In recent years, governments worldwide have implemented sugar taxes, prompting manufacturers to aggressively reformulate products with artificial sweeteners and sugar alcohols to maintain consumer appeal while avoiding financial penalties.

Public health organizations have long championed low-calorie sweeteners as a practical tool in the global fight against obesity, type 2 diabetes, and cardiovascular disease. However, emerging research increasingly suggests that human biology reacts to these synthetic and heavily processed compounds in complex ways that extend far beyond simple caloric reduction. Recent studies have raised parallel concerns regarding potential links between certain sugar substitutes, gut microbiota alterations, and cardiovascular events.

Dr. Suemoto and her colleagues emphasize that while the current study does not warrant immediate panic or a complete ban on artificial sweeteners, it serves as a powerful reminder that "zero calorie" does not equate to "zero biological impact."

As research continues, nutritionists and medical professionals are encouraging consumers to practice moderation and critically evaluate their overall consumption of ultra-processed foods. For individuals seeking sweet alternatives, researchers suggest exploring whole-food options—such as moderate amounts of honey, maple syrup, or fruit purees—while awaiting further clinical trials to clarify the long-term neurological safety of modern sugar substitutes. The study was supported by major Brazilian public health and scientific agencies, including the Ministry of Health, the Ministry of Science, Technology, and Innovation, and the National Council for Scientific and Technological Development, underscoring the international priority placed on understanding the environmental and dietary drivers of cognitive aging.